̽»¨ÊÓƵapp

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Apr. 30, 2019 $ 26,461,428 $ (136,745) $ 18,666 $ 68,562,727 $ (70,000) $ (42,049,965) $ (136,745)
Beginning balance (in shares) at Apr. 30, 2019 Ìý Ìý 18,665,551 Ìý Ìý Ìý Ìý
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 498,417 Ìý Ìý 498,417 Ìý Ìý Ìý
Common stock issued for cashless stock options exercised 0 Ìý $ 102 (102) Ìý Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý Ìý 101,894 Ìý Ìý Ìý Ìý
Common stock issued for stock options exercised for cash 45,190 Ìý $ 22 45,168 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý Ìý 21,876 Ìý Ìý Ìý Ìý
Common stock issued for cashless warrant exercise 0 Ìý $ 19 (19) Ìý Ìý Ìý
Common stock issued for cashless warrant exercise (in shares) Ìý Ìý 19,403 Ìý Ìý Ìý Ìý
Amortization of warrant based cost 9,440 Ìý Ìý 9,440 Ìý Ìý Ìý
Amortization of restricted stock issued for service 30,597 Ìý Ìý 30,597 Ìý Ìý Ìý
Restricted Stock Issued for Services, subject to vesting 0 Ìý $ 105 (105) Ìý Ìý Ìý
Restricted Stock Issued for Services, subject to vesting (in shares) Ìý Ìý 104,803 Ìý Ìý Ìý Ìý
Net loss (2,075,282) Ìý Ìý Ìý Ìý (2,075,282) Ìý
Ending balance at Jul. 31, 2019 24,833,045 Ìý $ 18,914 69,146,123 (70,000) (44,261,992) Ìý
Ending balance (in shares) at Jul. 31, 2019 Ìý Ìý 18,913,527 Ìý Ìý Ìý Ìý
Beginning balance at Apr. 30, 2020 41,747,957 Ìý $ 21,771 89,505,216 (70,000) (47,709,030) Ìý
Beginning balance (in shares) at Apr. 30, 2020 Ìý Ìý 21,770,520 Ìý Ìý Ìý Ìý
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 487,110 Ìý Ìý 487,110 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash 1,269,982 Ìý $ 415 1,269,567 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý Ìý 415,175 Ìý Ìý Ìý Ìý
Common stock issued for warrants exercised for cash 1,081,792 Ìý $ 192 1,081,600 Ìý Ìý Ìý
Common stock issued for warrants exercised for cash (in shares) Ìý Ìý 192,049 Ìý Ìý Ìý Ìý
Modification charge for warrants exercised 25,966 Ìý Ìý 25,966 Ìý Ìý Ìý
Amortization of warrant based cost 9,125 Ìý Ìý 9,125 Ìý Ìý Ìý
Net loss (943,196) Ìý Ìý Ìý Ìý (943,196) Ìý
Ending balance at Jul. 31, 2020 $ 43,678,736 Ìý $ 22,378 $ 92,378,584 $ (70,000) $ (48,652,226) Ìý
Ending balance (in shares) at Jul. 31, 2020 Ìý Ìý 22,377,744 Ìý Ìý Ìý Ìý